BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 32671416)

  • 1. Magnetic resonance imaging diagnosis of subependymal giant cell astrocytomas in follow-up of children with tuberous sclerosis complex: should we always use contrast enhancement?
    Gaillard AL; Crombé A; Jecko V; Bessou P; Havez M; Pédespan JM; Van Gils J; Chateil JF
    Pediatr Radiol; 2020 Sep; 50(10):1397-1408. PubMed ID: 32671416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation.
    Katz JS; Frankel H; Ma T; Zagzag D; Liechty B; Zeev BB; Tzadok M; Devinsky O; Weiner HL; Roth J
    Childs Nerv Syst; 2017 Apr; 33(4):601-607. PubMed ID: 28074282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
    Weidman DR; Palasamudram S; Zak M; Whitney R; McCoy B; Bouffet E; Taylor M; Shroff M; Bartels U
    J Neurooncol; 2020 May; 147(3):731-736. PubMed ID: 32285309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subependymal Giant Cell Astrocytoma Size Measurement in Tuberous Sclerosis Complex: Noncontrast vs Contrast-Enhanced 3-Dimensional T1-Weighted Magnetic Resonance Imaging (MRI).
    Hill BJ; Gadde JA; Palasis S
    J Child Neurol; 2019 Dec; 34(14):922-927. PubMed ID: 31424303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated subependymal giant cell astrocytoma (SEGA) in the absence of clinical tuberous sclerosis: two case reports and literature review.
    Cobourn KD; Chesney KM; Mueller K; Fayed I; Tsering D; Keating RF
    Childs Nerv Syst; 2024 Jan; 40(1):73-78. PubMed ID: 37658938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas.
    Bongaarts A; van Scheppingen J; Korotkov A; Mijnsbergen C; Anink JJ; Jansen FE; Spliet WGM; den Dunnen WFA; Gruber VE; Scholl T; Samueli S; Hainfellner JA; Feucht M; Kotulska K; Jozwiak S; Grajkowska W; Buccoliero AM; Caporalini C; Giordano F; Genitori L; Coras R; Blümcke I; Krsek P; Zamecnik J; Meijer L; Scicluna BP; Schouten-van Meeteren AYN; Mühlebner A; Mills JD; Aronica E
    Brain; 2020 Jan; 143(1):131-149. PubMed ID: 31834371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurosurgical treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex: a series of 44 surgical procedures in 31 patients.
    Giordano F; Moscheo C; Lenge M; Biagiotti R; Mari F; Sardi I; Buccoliero AM; Mongardi L; Aronica E; Guerrini R; Genitori L
    Childs Nerv Syst; 2020 May; 36(5):951-960. PubMed ID: 31853898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-level response rates of mTor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
    Weidman DR; Pole JD; Bouffet E; Taylor MD; Bartels U
    Pediatr Blood Cancer; 2015 Oct; 62(10):1754-60. PubMed ID: 25929843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the growth rate of subependymal giant cell astrocytoma and age in patients with tuberous sclerosis complex.
    Tsai JD; Wei CC; Tsao TF; Hsiao YP; Tsai HJ; Yang SH; Tsai ML; Sheu JN
    Childs Nerv Syst; 2016 Jan; 32(1):89-95. PubMed ID: 26552385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trapped ventricle after laser ablation of a subependymal giant cell astrocytoma complicated by intraventricular gadolinium extravasation: case report.
    Karsy M; Patel DM; Bollo RJ
    J Neurosurg Pediatr; 2018 May; 21(5):523-527. PubMed ID: 29451453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis.
    Nabbout R; Santos M; Rolland Y; Delalande O; Dulac O; Chiron C
    J Neurol Neurosurg Psychiatry; 1999 Mar; 66(3):370-5. PubMed ID: 10084537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Subependymal Giant Cell Astrocytoma with Tuberous Sclerosis Complex(TSC-SEGA)].
    Ichikawa T; Niida Y
    No Shinkei Geka; 2022 Jan; 50(1):111-121. PubMed ID: 35169091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSC2 somatic mosaic mutation, including extra-tumor tissue, may be the developmental cause of solitary subependymal giant cell astrocytoma.
    Sasaki T; Uda T; Kuki I; Kunihiro N; Okazaki S; Niida Y; Goto T
    Childs Nerv Syst; 2022 Jan; 38(1):77-83. PubMed ID: 34741623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A management strategy for intraventricular subependymal giant cell astrocytomas in tuberous sclerosis complex.
    Harter DH; Bassani L; Rodgers SD; Roth J; Devinsky O; Carlson C; Wisoff JH; Weiner HL
    J Neurosurg Pediatr; 2014 Jan; 13(1):21-8. PubMed ID: 24180681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment strategies for subependymal giant cell astrocytoma (SEGA).
    Ebrahimi-Fakhari D; Franz DN
    Expert Opin Pharmacother; 2020 Aug; 21(11):1329-1336. PubMed ID: 32338549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subependymal giant cell tumors in tuberous sclerosis complex.
    Goh S; Butler W; Thiele EA
    Neurology; 2004 Oct; 63(8):1457-61. PubMed ID: 15505165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful everolimus therapy for SEGA in pediatric patients with tuberous sclerosis complex.
    Cappellano AM; Senerchia AA; Adolfo F; Paiva PM; Pinho R; Covic A; Cavalheiro S; Saba N
    Childs Nerv Syst; 2013 Dec; 29(12):2301-5. PubMed ID: 23743818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraventricular lesions in tuberous sclerosis complex: a possible association with the caudate nucleus.
    Katz JS; Milla SS; Wiggins GC; Devinsky O; Weiner HL; Roth J
    J Neurosurg Pediatr; 2012 Apr; 9(4):406-13. PubMed ID: 22462706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.
    Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ
    J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature.
    Adriaensen ME; Schaefer-Prokop CM; Stijnen T; Duyndam DA; Zonnenberg BA; Prokop M
    Eur J Neurol; 2009 Jun; 16(6):691-6. PubMed ID: 19236458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.